138 results on '"Maio, Rui"'
Search Results
102. Erythropoietin Preserves the Integrity and Quality of Organs for Transplantation After Cardiac Death
- Author
-
Maio, Rui, primary, Sepodes, Bruno, additional, Patel, Nimesh S. A., additional, Thiemermann, Christoph, additional, Mota-Filipe, Helder, additional, and Costa, Paulo, additional
- Published
- 2011
- Full Text
- View/download PDF
103. Laparoscopic Placement of Tenckhoff Catheters for Peritoneal Dialysis: A Safe, Effective, and Reproducible Procedure
- Author
-
Maio, Rui, primary, Figueiredo, Nuno, additional, and Costa, Paulo, additional
- Published
- 2008
- Full Text
- View/download PDF
104. The role of a basic surgical skills laboratory as viewed by medical students (6th year).
- Author
-
da Costa, Paulo M., Santos, José, Maio, Rui, Santos, Antónia, and Paredes, Fernando
- Subjects
SURGICAL education ,MEDICAL education ,MEDICAL students ,ATTITUDE (Psychology) - Abstract
In the last academic year, a training period in a surgical skills laboratory, using plastic models, was included as a part of the 'Cirurgia 3' ('Surgery 3', 6th year) programme of Faculdade Medicina Lisboa. To evaluate the training period, a structured, anonymous questionnaire was administered at the end, seeking students' responses on their satisfaction in attending the course. A global view of the answers points out students' favourable opinion of the laboratory-training period: concerning students' perceived goals for attending the course, a high degree of satisfaction was reported (globally 73% of computed scores were rated as 'good' or 'very good'); the teaching/learning environment and the delivered content got 90% 'very good' and 'good' ratings; teaching staff performance got the highest percentage of rating scores 'very good' and 'good' (95%). These ratings were dependent on variables that are unlikely to be a reflection only of glamour and seduction (clear explanations and clear demonstration of each component of the skill) and were less dependent on other variables such as 'enthusiasm for teaching' and 'relationship with students', which could be expected to be influenced by the charisma of the tutors. Helping students learn and train in surgical skills in a laboratory is challenging and our results affirm that the environment and the content were valuable for the understanding of the subject, while sessions planning and appropriate teaching technique are essential when practical skills are to be taught and learned. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
105. A estabilidade estrutural e a vulnerabilidade dos edifícios em centros históricos face ao risco sísmico
- Author
-
Vicente, Romeu, Ferreira, Tiago Miguel, Maio, Rui, Estêvão, João M. C., and Hugo Rodrigues
- Subjects
Gestão de risco sísmico ,Estratégias de intervenção ,vulnerabilidade sísmica ,Centros históricos ,Cenários de dano - Abstract
Presentemente os países europeus estão a despertar para uma cultura da gestão de risco integrado, quer a nível nacional quer em termos municipais. A gestão de risco é um processo que engloba uma série de ações que apoiam a implementação de medidas que reduzam o potencial de perda na ocorrência de um evento, por exemplo, de natureza sísmica. Porém, a avaliação do risco sísmico é apenas uma das tarefas da teia complexa da gestão de risco e definição de estratégias de intervenção e controlo de um sistema urbano. De entre muitos objetivos que se perspetivam no âmbito do planeamento e gestão urbana, com este artigo abordar a avaliação de risco no domínio específico da segurança estrutural, com enfoque na avaliação do risco sísmico, cujas graves consequências fazem parte da nossa memória coletiva e, infelizmente, em alguns casos, da memória viva de diversas comunidades. A gravidade dos danos que deles decorrem é motivo suficiente para uma forte valorização das estratégias de prevenção, planeamento e mitigação que diminuam a sua probabilidade, limitem as suas consequências e permitam uma ação continuada de melhoria, já que só utopicamente se poderá considerar a possibilidade de transformação integral e imediata das realidades urbanas em situações de risco “zero”. info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/publishedVersion
106. Seismic vulnerability assessment of existing masonry buildings: Case study of the old city centre of Faro, Portugal
- Author
-
Vicente, Romeu, Ferreira, Tiago, Maio, Rui, Varum, Humberto, Costa, Alexandre A., Costa, Aníbal, Oliveira, Carlos S., and Estêvão, João
- Subjects
11. Sustainability
107. PRE-TREATMENT OF THE DONOR WITH ERYTHROPOIETIN AND TREATMENT OF THE RECIPIENT WITH 5-AIQ IMPROVES THE QUALITY OF ORGANS FROM DONORS AFTER CARDIAC DEATH (DCD), IN EXPERIMENTAL KIDNEY TRANSPLANTATION
- Author
-
Maio, Rui, Figueiredo, Nuno, Santos, Isa, Bruno Sepodes, Thiemermann, Christoph, Mota-Filipe, Helder, Costa, Paulo, and Repositório da Universidade de Lisboa
- Subjects
Critical Care Medicine ,Peripheral Vascular Disease ,Surgery ,Hematology - Abstract
Made available in DSpace on 2015-12-30T10:17:20Z (GMT). No. of bitstreams: 0 Previous issue date: 2009
108. Pre-treat the donor with erythropoietin and treat the recipient with 5-aminoisoquinolinone
- Author
-
Maio, Rui, Figueiredo, Nuno, Santos, Isa, Bruno Sepodes, Mota-Filipe, Helder, Thiemermann, Christoph, Costa, Paulo, and Repositório da Universidade de Lisboa
- Subjects
Transplantation ,Surgery - Abstract
Made available in DSpace on 2015-12-30T10:17:19Z (GMT). No. of bitstreams: 0 Previous issue date: 2008
109. The effect of 5-aminoisoquinolinone during machine perfusion of kidneys recovered after cardiac death (Experimental study)
- Author
-
Figueiredo, Nuno, Maio, Rui, Santos, Isa, Sepodes, Bruno, Thiemermann, Christoph, Helder Mota-Filipe, Costa, Paulo, and Repositório da Universidade de Lisboa
- Subjects
Transplantation ,Surgery - Abstract
Made available in DSpace on 2015-12-30T10:17:19Z (GMT). No. of bitstreams: 0 Previous issue date: 2008
110. Donor pre-treatment with erythropoietin - A way to improve the quality of organs from donation after cardiac death (experimental study)
- Author
-
Maio, Rui F., Figueiredo, Nuno L., Bruno Sepodes, Thiemermann, Christoph, Mota-Filipe, Helder, and Costa, Paulo M.
111. The effect of donor pre-treatment with erythropoietin in machine perfusion parameters (Experimental study)
- Author
-
Figueiredo, Nano L., Maio, Rui F., Bruno Sepodes, Thiemermann, Christoph, Mota-Filipe, Helder, and Costa, Paulo M.
112. Biological and surgical determinants in the treatment of rectal cancer
- Author
-
Ourô, Susana Margarida Rodrigues, Maio, Rui, Rodrigues, Cecília, and Braga, Sofia
- Subjects
Cancro do recto ,MicroRNAs-21 ,MicroRNAs ,MicroRNAs 21 ,Ileostomy ,Ciências Médicas ,Local, excision ,Ileostomia ,Excisão local ,Rectal cancer ,Transanal total mesorectal excision ,Excisão total do mesorecto via transanal - Abstract
RESUMO: O cancro do recto é uma doença muito complexa que tem vindo a aumentar nas idades mais jovens com um enorme impacto na qualidade de vida. Esta é uma patologia extremamente heterogénea no que concerne ao seu comportamento, dependente de vários factores que determinam não só o seu curso mas a resposta à terapêutica. Nas últimas décadas progressos significativos têm sido feitos na abordagem do cancro do recto devido a um melhor conhecimento da fisiopatologia da doença, conduzindo ao aparecimento de novas opções de tratamento. De forma síncrona com uma evolução técnica, o conceito terapêutico também se alterou, mudando de uma perspectiva exclusivamente focada nos outcomes oncológicos para um modelo com preocupações relacionadas com os resultados funcionais e a qualidade de vida. O ênfase passou também a residir na minimização dos efeitos deletérios do tratamento. Esta é a interrogação na base deste trabalho: é possível encontrar determinantes biológicos e cirúrgicos do tratamento do cancro do recto por forma a diminuir a morbilidade associada à terapêutica mas obtendo igualmente os resultados pretendidos? Existem vários factores biológicos que influenciam os resultados terapêuticos do cancro do recto mas verifica-se, igualmente, um inquestionável impacto da opção cirúrgica selecionada. Sendo a nossa meta a obtenção dos melhores resultados com a menor morbilidade, é necessário procurar estes determinantes biológicos e cirúrgicos do tratamento óptimo. O objectivo deste projeto é analisar possíveis determinantes da terapêutica do cancro do recto. São colocadas as seguintes questões: 1) poderemos optimizar a seleção dos doentes para quimioradioterapia neoadjuvante através da identificação de marcadores moleculares de resposta?, 2) poderemos melhor selecionar a técnica cirúrgica nomeadamente com a excisão total do mesorecto via transanal ou a excisão local em casos específicos? e 3) será possível uma melhor escolha dos doentes para ileostomia derivativa através da identificação de factores preditivos de morbilidade associada a este estoma? A terapêutica neoadjuvante é atualmente administrada aos doentes com adenocarcinoma localmente avançado do recto, maioritariamente com boa resposta tumoral. Contudo, cerca de um terço dos doentes submetidos a quimioradioterapia não beneficiam deste tratamento, têm risco acrescido de progressão de doença durante o mesmo bem como de toxicidade desnecessária. Até hoje, não foram ainda validados quaisquer marcadores preditivos de resposta à quimioradioterapia que possam ajudar na seleção dos doentes para esta terapêutica. Tendo em conta o seu papel na oncogénese do cancro do recto bem como o seu envolvimento na resposta ao tratamento médico, colocámos a hipótese de os microRNAs em particular microRNA-16, microRNA-21, microRNA-135b, microRNA-145 e o microRNA-335 poderem ser biomarcadores de resposta à quimioradioterapia, predizendo os bons e os maus respondedores. Foi encontrada uma associação estatisticamente significativa entre a sobre-expressão de microRNA-21 no tecido tumoral pré- quimioradioterapia e pior resposta à mesma. Os nossos resultados sugerem a possibilidade do microRNAs-21 ser um biomarcador de resposta patológica à quimioradioterapia no cancro do recto. A confirmação desta associação poderá ter uma translação para a prática clínica corrente, com a inclusão do miRNA nos algoritmos de decisão terapêutica, possibilitando uma melhor seleção dos candidatos a quimioradioterapia. Durante os últimos 30 anos, grandes progressos cirúrgicos foram introduzidos no cancro do recto com vista à melhoria dos outcomes e diminuição da morbilidade associada ao tratamento. O mais recente avanço neste âmbito é a excisão total do mesorecto via transanal introduzida em 2010, com resultados a curto prazo muito positivos. Contudo, os outcomes a longo prazo são ainda controversos. Analisámos os outcomes oncológicos dos primeiros 50 doentes submetidos a esta técnica na nossa instituição e procedemos à sua comparação com os obtidos por um grupo equiparado de doentes submetidos a excisão total do mesorecto laparoscópica. Mesmo refletindo a curva de aprendizagem da nova técnica, foram encontrados valores semelhantes entre os grupos no que concerne a sobrevivência global, sobrevivência livre de doença e recidiva local a curto e longo prazo. Estes resultados apontam para que a excisão total do mesorecto via transanal possa produzir outcomes oncológicos seguros, compatíveis com o que tem sido publicado para a abordagem laparoscópica. Contudo, este estudo também enfatiza a sua exigente curva de aprendizagem e o risco significativo de morbilidade que lhe está associado. Na realidade, qualquer que seja a opção cirúrgica utilizada no tratamento do cancro do recto distal, é necessária elevada proficiência, sendo que resultados óptimos só se atingem com treino adequado e auditoria contínua como garante da sua melhoria à medida que a experiência aumenta. Entendendo a excisão total do mesorecto como um dos grandes avanços no tratamento do cancro do recto, não podemos deixar de reconhecer o seu impacto negativo na qualidade de vida dos doentes com tumores distais. Neste contexto começaram a ser ponderadas estratégias terapêuticas menos agressivas com vista a uma menor morbilidade, nomeadamente quimioradioterapia seguida de excisão local. Através de uma revisão sistemática com metanálise que comparou, em contexto de neoadjuvância, os outcomes da excisão local com os da cirurgia radical, encontrámos valores de recidiva local, sobrevivência global e livre de doença semelhantes entre os grupos. Estes resultados podem ser explicados pelo facto de o mais importante determinante oncológico não ser o estadiamento inicial mas sim o pós quimioradioterapia, refletindo o comportamento biológico do tumor. No entanto, alguns estudos incluídos nesta metanálise apenas mostraram o estadiamento inicial. Na realidade, após a quimioradioterapia, a excisão local parece ser uma alternativa nos doentes com tumor restrito à submucosa e sem adenopatias objectiváveis (ycT1N0), nos doentes com co-morbilidades ou que recusam cirurgia radical. Na cirurgia de excisão total do mesorecto é frequentemente realizada ileostomia derivativa por forma a reduzir as consequências do leak anastomótico. Contudo, a maioria dos doentes não enfrenta esta complicação sendo desnecessariamente exposta à potencial morbilidade do estoma. De facto, o efeito protetor do estoma derivativo deve ser contrabalançado com a sua morbilidade, bastante relevante. Tendo investigado marcadores de complicações associadas à ileostomia, identificámos a Diabetes Mellitus e a morbilidade da cirurgia rectal índex como factores preditivos não só de maior morbilidade associada ao estoma e ao seu encerramento bem como de menor encerramento. Assim, quando ponderamos a realização de uma ileostomia derivativa na cirurgia do recto, há que ter em conta a influência destes fatores preditivos de morbilidade. É essencial individualizar as decisões terapêuticas e adoptar uma abordagem mais seletiva no uso do estoma derivativo, especialmente nos doentes em que o risco do mesmo pode superar as potenciais vantagens. Em suma, existem vários factores que influenciam a conduta terapêutica na abordagem do cancro do recto. Existem determinantes biológicos e cirúrgicos do tratamento desta doença que necessitam de ser estudados, com vista ao atingir dos melhores resultados com a menor morbilidade. O papel dos microRNAs na oncogénese é inquestionável como o é a influência de microRNAs específicos, nomeadamente o microRNA-21, na resposta à quimioradioterapia neoadjuvante. Igualmente, também é crítica a opção cirúrgica nos diferentes contextos clínicos. De facto, podemos individualizar as intervenções cirúrgicas através do uso seletivo da excisão total do mesorecto via transanal nos tumores distais ou da excisão local pós quimioradioterapia nos doentes de alto risco com boa resposta, confinada à submucosa. Igualmente, antes da realização de cirurgia de excisão radical, é imperativo optimizar o status geral do doente e controlar factores de risco modificáveis como a Diabetes Mellitus por forma a diminuir igualmente a morbilidade associada ao estoma de proteção. ABSTRACT:Rectal cancer (RC) is a very complex disease that has been increasing in younger patients, imposing a great impact in quality of life. It is an extremely heterogeneous pathology in what regards to behaviour, which is dependent of many factors that determine its course and response to treatment. In the past decades, significant progress has been made in the management of RC due to a better knowledge of disease pathophysiology and consequent development of new therapeutic options. Synchronously with the technical evolution, the concept of oncological treatment also changed, from a perspective exclusively focused on survival outcomes to a model involving concerns with functional results and quality of life. Emphasis changed to minimizing the deleterious effects of treatment. However, many rectal cancer patients are still submitted to medical therapies and surgical options without any benefit and that even add unjustified morbidity. This is the core question of this work: can we find biological and surgical determinants of RC treatment in order to decrease its related morbidity while achieving the intended outcomes? There are biological factors that influence clinical results and there is an undeniable impact of the surgical options we select. As our goal is obtaining the best possible outcomes minimizing morbidity, we must search for the biological and surgical determinants guidelining the optimal treatment. The aim of this project is to provide new insights to possible determinants of RC treatment. We ask the following questions: 1) can we better select patients for chemoradiotherapy through the identification of molecular predictors of response?, 2) can we individualize the surgical technique for each RC patient, using transanal total mesorectal excision or local excision in selected cases? and 3) can we improve assortment of patients for a derivative ileostomy identifying factors predictive of related morbidity? Neoadjuvant therapy is currently given to the majority of locally advanced rectal cancer with a majority of good tumour response. However, one third of patients that undergo chemoradiotherapy do not profit from this option, are at increased risk of disease progression and even unnecessary toxicity. So far, there are no validated predictors of response to chemoradiotherapy to aid in deciding whether the patient should or not undergo this therapy, avoiding related morbidity. Considering their role in rectal cancer oncogenesis and involvement in the response to medical therapies, we hypothesized that microRNAs (miRNAs or miRs), in particular microRNA-16, microRNA-21, microRNA-135b, microRNA-145 and microRNA-335 are biomarkers of response to neoadjuvant CRT, predicting good and bad responders. We found a statistically significant association of microRNA-21 overexpression in pre- chemoradiotherapy rectal cancer tissue and worse response. Our results suggest that microRNA-21 may, indeed, be a biomarker of pathological response in rectal cancer. Confirmation as such could translate into clinical application through the inclusion of the levels of microRNA-21 in algorithms of treatment decision, certainly allowing a better selection of candidates for chemoradiotherapy During the last 30 years, great surgical progress was introduced in RC treatment aiming to improve outcomes and diminishing the morbidity associated with treatment. The most recent of theses attempts is transanal total mesorectal excision, developed in 2010, which yielded very positive short-term results. However, long-term outcomes are still controversial and not clarified. We analysed the oncological outcomes of the learning curve of this technique at our institution and compared them to a matched cohort of patients submitted to the standard of care laparoscopic total mesorectal excision. Similar long-term results regarding local recurrence, overall survival and disease-free survival were found. These results point out to the fact that transanal total mesorectal excision can produce short and long-term oncological safe results, compatible to what has been published for the laparoscopic approach. However, this work also emphasized the demanding learning curve and significant risk for morbidity associated with this novel technique. The fact is that, whatever option is used to performed distal RC surgery, it requires advanced surgical skills and optimal results can only be achieved with adequate training and continuous evaluation of outcomes to ensure they improve as experience grows. Transanal total mesorectal excision does not intent to replace other established approaches to rectal surgery but to add new alternatives to address difficult cases. As we understand TME as one of the greatest revolutions of rectal cancer treatment we also acknowledge its negative impact on the quality of life of patients with distal tumours. In this setting, less aggressive therapeutic strategies started to be discussed in order to decrease therapeutic morbidity, namely neoadjuvant chemoradiotherapy combined with local excision. Through a systematic review and meta analysis that compared the outcomes of local excision and radical surgery in the post neoadjuvant setting, we found similar outcomes between groups in relation to local recurrence, overall survival and disease-free survival. These results are explained by the fact that the most relevant determinant of local recurrence and survival is not the baseline staging but the post chemoradiotherapy one, that reflects tumour biologic behaviour. However, some studies included in this metanalysis were based on initial staging. In sum, after CRT, patients with an incomplete response contained in the mucosa or submucosa with negative nodes (ycT1N0) may be an indication for LE. This strategy can also be considered in trial setting or as an option for patients refusing abdominoperineal resection or with significant comorbidity. Still in rectal cancer surgery, defunctioning ileostomy is frequently constructed to reduce the poor consequences of a leak. However, the majority of patients does not face anastomotic breakdown and is unnecessarily exposed to stoma potential complications. In fact, stoma protective effect needs to be balanced against its morbidity, which is actually quite high. We identified Diabetes Mellitus and complications of the index rectal surgery as predictive of higher ileostomy morbidity and of closure-related problems as well as lower ileostomy reversal. So, when deciding over diverting a colorectal or coloanal anastomosis, the influence of these predictive factors must be taken into account. It is essential to individualize treatment decisions and adopt a more selective approach concerning the use of a defunctioning ileostomy, especially for patients in which the risks of having a stoma may offset potential advantages. In summary, there are many factors influencing the proper therapeutic conduct to follow in the approach of rectal cancer. There are biological and surgical determinants of the treatment of this disease that need to be analysed, in order to achieve the best results with the lowest morbidity. The role of the microRNA in oncogenic pathways is undeniable as is the influence of specific microRNA, namely miR-21, in the response to chemoradiotherapy. Likewise, the choice of particular surgical interventions in different clinical settings can be critical to obtain the appropriate outcomes. We can individualize surgical options through the selective use of transanal total mesorectal excision in distal tumours or local excision in high risk patients with very good response, confined to the submucosa, in post neoadjuvant treatment. Likewise, prior to performing radical surgery, it is imperative to optimize patients and control modifiable risk factors as diabetes mellitus in order to decrease stoma-related morbidity.
- Published
- 2022
113. Relatório estágio profissional
- Author
-
Abecasis, Maria Rita de Moura Guedes and Maio, Rui
- Subjects
Pediatria ,Cirurgia ,Ginecologia e Obstetrícia ,Medicina ,Ciências Médicas ,Medicina Geral e Familiar ,Saúde Mental - Abstract
Relatório final do estágio profissionalizante do 6.ºano
- Published
- 2021
114. Relatório estágio profissional
- Author
-
Santos , João Pedro Gibert Alvarez Betencourt dos and Maio, Rui
- Subjects
Pediatria ,Cirurgia ,Ginecologia e Obstetrícia ,Medicina ,Ciências Médicas ,Medicina Geral e Familiar ,Saúde Mental - Abstract
Relatório final do estágio profissionalizante do 6.º ano.
- Published
- 2021
115. Relatório estágio profissional
- Author
-
Lopes, Melanie Siopa Cardoso and Maio, Rui
- Subjects
Pediatria ,Cirurgia ,Ginecologia e Obstetrícia ,Medicina ,Ciências Médicas ,Medicina Geral e Familiar ,Saúde Mental - Abstract
Relatório final do estágio profissionalizante do 6.º ano
- Published
- 2021
116. Relatório estágio profissional
- Author
-
Silva, Mónica Paula do Souto Dias Martel da and Maio, Rui
- Subjects
Pediatria ,Cirurgia ,Ginecologia e Obstetrícia ,Medicina ,Ciências Médicas ,Medicina Geral e Familiar ,Saúde Mental - Abstract
Relatório final do estágio profissionalizante do 6.ºano
- Published
- 2021
117. Relatório estágio profissional
- Author
-
Pereira, Luís Carlos da Cruz and Maio, Rui
- Subjects
Pediatria ,Cirurgia ,Ginecologia e Obstetrícia ,Medicina ,Ciências Médicas ,Medicina Geral e Familiar ,Saúde Mental - Abstract
Relatório final do estágio profissionalizante do 6.º ano
- Published
- 2021
118. Relatório estágio profissional
- Author
-
Pereira, Ana Catarina Raposo and Maio, Rui
- Subjects
Pediatria ,Cirurgia ,Ginecologia e Obstetrícia ,Medicina ,Ciências Médicas ,Medicina Geral e Familiar ,Saúde Mental - Abstract
Relatório final do estágio profissionalizante do 6.º ano
- Published
- 2020
119. Seismic vulnerability of building aggregates through hybrid and indirect assessment techniques
- Author
-
Romeu Vicente, Antonio Formisano, Rui Maio, Humberto Varum, Maio, Rui, Vicente, Romeu, Formisano, Antonio, and Varum, Humberto
- Subjects
Engineering ,Hydrogeology ,Aggregate (composite) ,Vulnerability index ,business.industry ,Vulnerability ,Building aggregate ,Building and Construction ,Masonry ,Geotechnical Engineering and Engineering Geology ,Civil engineering ,Seismic vulnerability ,Seismic analysis ,Geophysics ,Macro-element ,Fragility curve ,Vulnerability assessment ,Retrofitting ,business ,Geophysic ,Damage distribution ,Civil and Structural Engineering - Abstract
This work approaches the seismic vulnerability assessment of an old stone masonry building aggregate, located in San Pio delle Camere (Abruzzo, Italy), slightly affected by the 2009 April 6th earthquake occurred in L’Aquila and its districts. This building aggregate has been modelled by using the 3muri® software for seismic analysis of masonry constructions. On one hand, static non-linear numerical analyses were performed to obtain capacity curves together with the prediction of damage distributions for the input seismic action (hybrid technique). On the other hand, indirect techniques, based on different vulnerability index formulations, were used for assessing the building aggregate’s behaviour under earthquake action. The activities carried out have provided a clear framework on the seismic vulnerability of building aggregates, as well as aid future retrofitting interventions.
- Published
- 2015
120. Bringing Hope to Improve Treatment in Pancreatic Ductal Adenocarcinoma-A New Tool for Molecular Profiling of KRAS Mutations in Tumor and Plasma Samples.
- Author
-
Bravo AC, Morão B, Luz A, Dourado R, Oliveira B, Guedes A, Moreira-Barbosa C, Fidalgo C, Mascarenhas-Lemos L, Costa-Santos MP, Maio R, Paulino J, Viana Baptista P, Fernandes AR, and Cravo M
- Abstract
Background/objectives: Pancreatic ductal adenocarcinoma (PDAC) incidence is rising, and prognosis remains poor due to late diagnosis and limited effective therapies. Currently, patients are treated based on TNM staging, without molecular tumor characterization. This study aimed to validate a technique that combines the amplification refractory mutation system (ARMS) with high-resolution melting analysis (HRMA) for detecting mutations in codon 12 of KRAS in tumor and plasma, and to assess its prognostic value., Methods: Prospective study including patients with newly diagnosed PDAC with tumor and plasma samples collected before treatment. Mutations in codon 12 of KRAS (G12D, G12V, G12C, and G12R) were detected using ARMS-HRMA and compared to Sanger sequencing (SS). Univariate and multivariate analyses were used to evaluate the prognostic significance of these mutations., Results: A total of 88 patients, 93% with ECOG-PS 0-1, 57% with resectable disease. ARMS-HRMA technique showed a higher sensitivity than SS, both in tumor and plasma (77% vs. 51%; 25 vs. 0%, respectively). The most frequent mutation was G12D (n = 32, 36%), followed by G12V (n = 22, 25%). On multivariate analysis, patients with G12D and/or G12C mutations, either in tumor or plasma, had lower PFS (HR 1.792, 95% CI 1.061-3.028, p = 0.029; HR 2.081, 95% CI 1.014-4.272, p = 0.046, respectively) and lower OS (HR 1.757, 95% CI 1.013-3.049, p = 0.045; HR 2.229, 95% CI 1.082-4.594, p = 0.030, respectively)., Conclusions: ARMS-HRMA is a rapid and cost-effective method for detecting KRAS mutations in PDAC patients, offering the potential for stratifying prognosis and guiding treatment decisions. The presence of G12D and G12C mutations in both tumor and plasma is associated with a poorer prognosis.
- Published
- 2024
- Full Text
- View/download PDF
121. Acute venous thromboembolism plasma and red blood cell metabolomic profiling reveals potential new early diagnostic biomarkers: observational clinical study.
- Author
-
Febra C, Saraiva J, Vaz F, Macedo J, Al-Hroub HM, Semreen MH, Maio R, Gil V, Soares N, and Penque D
- Subjects
- Humans, Biomarkers, Erythrocytes, Risk Factors, Pulmonary Embolism, Venous Thromboembolism diagnosis, Venous Thromboembolism etiology, Venous Thrombosis
- Abstract
Background: Venous thromboembolism (VTE) is a leading cause of cardiovascular mortality. The diagnosis of acute VTE is based on complex imaging exams due to the lack of biomarkers. Recent multi-omics based research has contributed to the development of novel biomarkers in cardiovascular diseases. Our aim was to determine whether patients with acute VTE have differences in the metabolomic profile compared to non-acute VTE., Methods: This observational trial included 62 patients with clinical suspicion of acute deep vein thrombosis or pulmonary embolism, admitted to the emergency room. There were 50 patients diagnosed with acute VTE and 12 with non-acute VTE conditions and no significant differences were found between the two groups for clinical and demographic characteristics. Metabolomics assays identified and quantified a final number of 91 metabolites in plasma and 55 metabolites in red blood cells (RBCs). Plasma from acute VTE patients expressed tendency to a specific metabolomic signature, with univariate analyses revealing 23 significantly different molecules between acute VTE patients and controls (p < 0.05). The most relevant metabolic pathway with the strongest impact on the acute VTE phenotype was D-glutamine and D-glutamate (p = 0.001, false discovery rate = 0.06). RBCs revealed a specific metabolomic signature in patients with a confirmed diagnosis of DVT or PE that distinguished them from other acutely diseased patients, represented by 20 significantly higher metabolites and four lower metabolites. Three of those metabolites revealed high performant ROC curves, including adenosine 3',5'-diphosphate (AUC 0.983), glutathione (AUC 0.923), and adenine (AUC 0.91). Overall, the metabolic pathway most impacting to the differences observed in the RBCs was the purine metabolism (p = 0.000354, false discovery rate = 0.68)., Conclusions: Our findings show that metabolite differences exist between acute VTE and nonacute VTE patients admitted to the ER in the early phases. Three potential biomarkers obtained from RBCs showed high performance for acute VTE diagnosis. Further studies should investigate accessible laboratory methods for the future daily practice usefulness of these metabolites for the early diagnosis of acute VTE in the ER., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
122. Role of Endoscopic Biopsies and Morphologic Features in Predicting Microsatellite Instability Status in Gastric Cancer: A Multicenter Comparative Study of Endoscopic Biopsies and Surgical Specimens.
- Author
-
Silva JR, Mascarenhas-Lemos L, Neto do Nascimento C, Sousa Marques D, Wen X, Pinho L, Maio R, Pontes P, Cirnes L, Cravo M, Carneiro F, and Gullo I
- Subjects
- Humans, Microsatellite Instability, Retrospective Studies, Immunohistochemistry, Biopsy, DNA Mismatch Repair, Microsatellite Repeats, Stomach Neoplasms genetics, Stomach Neoplasms surgery, Stomach Neoplasms metabolism, Colorectal Neoplasms pathology
- Abstract
Evaluation of mismatch repair (MMR) protein and microsatellite instability (MSI) status plays a pivotal role in the management of gastric cancer (GC) patients. In this study, we aimed to evaluate the accuracy of gastric endoscopic biopsies (EBs) in predicting MMR/MSI status and to uncover histopathologic features associated with MSI. A multicentric series of 140 GCs was collected retrospectively, in which EB and matched surgical specimens (SSs) were available. Laurén and WHO classifications were applied and detailed morphologic characterization was performed. EB/SS were analyzed by immunohistochemistry (IHC) for MMR status and by multiplex polymerase chain reaction (mPCR) for MSI status. IHC allowed accurate evaluation of MMR status in EB (sensitivity: 97.3%; specificity: 98.0%) and high concordance rates between EB and SS (Cohen κ=94.5%). By contrast, mPCR (Idylla MSI Test) showed lower sensitivity in evaluating MSI status (91.3% vs. 97.3%), while maintaining maximal specificity (100.0%). These results suggest a role of IHC as a screening method for MMR status in EB and the use of mPCR as a confirmatory test. Although Laurén/WHO classifications were not able to discriminate GC cases with MSI, we identified specific histopathologic features that are significantly associated with MMR/MSI status in GC, despite the morphologic heterogeneity of GC cases harboring this molecular phenotype. In SS, these features included the presence of mucinous and/or solid components ( P =0.034 and <0.001) and the presence of neutrophil-rich stroma, distant from tumor ulceration/perforation ( P <0.001). In EB, both solid areas and extracellular mucin lakes were also discriminating features for the identification of MSI-high cases ( P =0.002 and 0.045)., Competing Interests: Conflicts of Interest and Source of Funding: Partially co-financed by Hospital da Luz under the initiative “Luz Investigação” in the context of the Group GENIUS (Reference LH.INV.F2019015). Part of the Idylla reagents have been provided free of charge by Biocartis. The funding source did not have any influence on the design, conduction, analysis, and interpretation of data and report of the results for this study. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
123. Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples.
- Author
-
Oliveira BB, Costa B, Morão B, Faias S, Veigas B, Pereira LP, Albuquerque C, Maio R, Cravo M, Fernandes AR, and Baptista PV
- Subjects
- Humans, Prognosis, Polymerase Chain Reaction methods, Mutation, Biomarkers, Tumor genetics, Proto-Oncogene Proteins p21(ras) genetics, Pancreatic Neoplasms
- Abstract
The success of personalized medicine depends on the discovery of biomarkers that allow oncologists to identify patients that will benefit from a particular targeted drug. Molecular tests are mostly performed using tumor samples, which may not be representative of the tumor's temporal and spatial heterogeneity. Liquid biopsies, and particularly the analysis of circulating tumor DNA, are emerging as an interesting means for diagnosis, prognosis, and predictive biomarker discovery. In this study, the amplification refractory mutation system (ARMS) coupled with high-resolution melting analysis (HRMA) was developed for detecting two of the most relevant KRAS mutations in codon 12. After optimization with commercial cancer cell lines, KRAS mutation screening was validated in tumor and plasma samples collected from patients with pancreatic ductal adenocarcinoma (PDAC), and the results were compared to those obtained by Sanger sequencing (SS) and droplet digital polymerase chain reaction (ddPCR). The developed ARMS-HRMA methodology stands out for its simplicity and reduced time to result when compared to both SS and ddPCR but showing high sensitivity and specificity for the detection of mutations in tumor and plasma samples. In fact, ARMS-HRMA scored 3 more mutations compared to SS (tumor samples T6, T7, and T12) and one more compared to ddPCR (tumor sample T7) in DNA extracted from tumors. For ctDNA from plasma samples, insufficient genetic material prevented the screening of all samples. Still, ARMS-HRMA allowed for scoring more mutations in comparison to SS and 1 more mutation in comparison to ddPCR (plasma sample P7). We propose that ARMS-HRMA might be used as a sensitive, specific, and simple method for the screening of low-level mutations in liquid biopsies, suitable for improving diagnosis and prognosis schemes., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
124. Correction: Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features.
- Author
-
Guerra A, Alves FC, Maes K, Joniau S, Cassis J, Maio R, Cravo M, and Mouriño H
- Published
- 2023
- Full Text
- View/download PDF
125. Body composition and Crohn's disease behavior: Is adiposity the main game changer?
- Author
-
Velho S, Morão B, Gouveia C, Agostinho L, Torres J, Maio R, Baracos VE, and Cravo M
- Subjects
- Humans, Retrospective Studies, Adiposity, Obesity, Abdominal complications, Tomography, X-Ray Computed, Crohn Disease complications
- Abstract
Objective: We investigated the association between body composition upon diagnosis and complicated phenotypes and time until surgery in patients with Crohn's disease (CD)., Methods: We conducted a retrospective cohort study including patients with CD who had a computed tomography enterography or a magnetic resonance enterography performed ≤6 mo of diagnosis. Skeletal muscle and visceral and subcutaneous adipose tissue cross-sectional areas were determined with computed tomography or magnetic resonance images at the third lumbar vertebral level, processed with the sliceOmatic (TomoVison, Magog, QC, Canada) and ABACS plugin., Results: We included 63 patients: 33 (52%) men, median age 35 y. Disease location (L) and behavior (B) according to the Montreal classification were L1 (ileal disease) = 28 (44%), L2 (colonic disease) = 13 (21%), L3(ileocolonic disease) = 18 (28%), L1 + L4 (ileal and isolated upper disease) = 1 (2%), L3 + L4 (ileocolonic and isolated upper disease) = 3 (5%), B1 (non-stricturing) = 39 (62%), B2 (stricturing) = 11 (17%), and B3 (penetrating)= 13 (21%); 20 (32%) patients had perianal disease. Visceral obesity was present in 12 (19%) patients and was associated with higher age of CD onset (median 60 versus 34 y; P = 0.002) and complicated disease behavior (B2 and B3) (66.7% versus 31.7%; P = 0.021). After adjusting for age and perianal disease, total adipose tissue was associated with a 4% increase in the odds of complicated behavior per 10 cm
2 of total adipose tissue (odds ratio [OR] = 1.004; 95% confidence interval [CI], 1.00-1.008; P = 0.043). Median follow-up time was 3.35 y, during which 15 (24%) of patients underwent abdominal surgery. Visceral obesity was associated with 5.10-times higher risk of abdominal surgery (95% CI, 1.52-17.09; P = 0.008); after adjusting for disease behavior, visceral obesity maintained a near-significant association with a 2.90-times higher risk of surgery (95% CI, 0.83-10.08; P = 0.09)., Conclusion: Total fat was associated with complicated disease phenotype and visceral obesity, with higher risk of abdominal surgery and shorter time until surgery., (Copyright © 2022 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
126. Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features.
- Author
-
Guerra A, Alves FC, Maes K, Joniau S, Cassis J, Maio R, Cravo M, and Mouriño H
- Subjects
- Male, Humans, Magnetic Resonance Imaging methods, Prospective Studies, Extranodal Extension pathology, Semantics, Neoplasm Staging, Prostatectomy methods, Biomarkers, Retrospective Studies, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms surgery, Prostatic Neoplasms pathology
- Abstract
Background: To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate cancer (PCa)., Methods: We performed a prospective 3 T MRI study comparing the clinical and MRI data on pECE obtained from patients treated using robotic-assisted radical prostatectomy (RARP) at our institution. The covariates under consideration were prostate-specific antigen (PSA) levels, the patient's age, prostate volume, and MRI interpretative features for predicting pECE based on the Prostate Imaging-Reporting and Data System (PI-RADS) version 2.0 (v2), as well as tumor capsular contact length (TCCL), length of the index lesion, and prostate biopsy Gleason score (GS). Univariable and multivariable logistic regression models were applied to explore the statistical associations and construct the model. We also recruited an additional set of participants-which included 59 patients from external institutions-to validate the model., Results: The study participants included 184 patients who had undergone RARP at our institution, 26% of whom were pECE+ (i.e., pECE positive). Significant predictors of pECE+ were TCCL, capsular disruption, measurable ECE on MRI, and a GS of ≥7(4 + 3) on a prostate biopsy. The strongest predictor of pECE+ is measurable ECE on MRI, and in its absence, a combination of TCCL and prostate biopsy GS was significantly effective for detecting the patient's risk of being pECE+. Our predictive model showed a satisfactory performance at distinguishing between patients with pECE+ and patients with pECE-, with an area under the ROC curve (AUC) of 0.90 (86.0-95.8%), high sensitivity (86%), and moderate specificity (70%)., Conclusions: Our predictive model, based on consistent MRI features (i.e., measurable ECE and TCCL) and a prostate biopsy GS, has satisfactory performance and sufficiently high sensitivity for predicting pECE+. Hence, the model could be a valuable tool for surgeons planning preoperative nerve sparing, as it would reduce positive surgical margins., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
127. Lymph node yield in the pathological staging of resected nonmetastatic colon cancer: The more the better?
- Author
-
Simões P, Fernandes G, Costeira B, Machete M, Baptista C, N Silva D, Leal-Costa L, Prazeres G, Correia J, Albuquerque J, Padrão T, Gomes C, Godinho J, Faria A, Casa-Nova M, Lopes F, Teixeira JA, F Pulido C, Oliveira H, Mascarenhas-Lemos L, Albergaria D, Maio R, and Passos-Coelho JL
- Subjects
- Humans, Lymph Node Excision, Neoplasm Staging, Prognosis, Retrospective Studies, Colonic Neoplasms pathology, Lymph Nodes pathology, Lymph Nodes surgery
- Abstract
Introduction: Guidelines recommend regional lymphadenectomy with a lymph node yield (LNY) of at least 12 lymph nodes (LN) for adequate colon cancer (CC) staging. LNY ≥22LN may improve survival, especially in right-sided CC [Lee et al., Surg Oncol, 27(3), 2018]. This multicentric retrospective cohort study evaluated the impact of LNY and tumor laterality on CC staging and survival., Materials and Methods: Patients with stage I-III CC that underwent surgery from 2012 to 2018 were grouped according to LNY: <22 and ≥ 22. Primary outcomes were LN positivity (N+ rate) and disease-free survival (DFS). Overall survival (OS) was the secondary outcome. Exploratory analyses were performed for laterality and stage., Results: We included 795 patients (417 < 22LN, 378 ≥ 22LN); 53% had left-sided CC and 29%/37%/38% had stage I/II/III tumors. There was no association between LNY ≥22LN and N+ rate after adjustment for grade, T stage, lymphovascular invasion (LVI) and perineural invasion; a trend for a higher N+ rate in left-sided CC was identified (interaction p = 0.033). With a median follow-up of 63.6 months for DFS and 73.2 months for OS, 254 patients (31.9%) relapsed and 207 (26.0%) died. In multivariate analysis adjusted for age, ASA score, laparoscopic approach, T/N stage, mucinous histology, LVI and adjuvant chemotherapy, LNY ≥22LN was significantly associated with both DFS (HR 0.75, p = 0.031) and OS (HR 0.71, p = 0.025). Restricted cubic spline analysis showed a more significant benefit for right-sided CC., Conclusion: LNY ≥22LN was associated with longer DFS and OS in patients with operable CC, especially for right-sided CC., Competing Interests: Declaration of competing interest This study was not supported by any specific grant from funding agencies, public or private. The authors declare no potential conflicts of interest., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
128. Phenotype-Genotype Correlation in Colorectal Cancer: A Real-Life Study.
- Author
-
Frias-Gomes C, Sousa AC, Rolim I, Henriques AR, Branco F, Janeiro A, Malveiro S, Dário AR, Oliveira MH, Borralho P, Teixeira JA, Faria A, Maio R, Fonseca I, and Cravo M
- Abstract
Background and Aims: Colorectal cancer (CRC) is a heterogeneous disease with distinctive genetic pathways, such as chromosomal instability, microsatellite instability and methylator pathway. Our aim was to correlate clinical and genetic characteristics of CRC patients in order to understand clinical implications of tumour genotype., Methods: Single-institution retrospective cohort of patients who underwent curative surgery for CRC, from 2012 to 2014. RAS and BRAF mutations were evaluated with the real-time PCR technique Idylla®. Mismatch repair deficiency (dMMR) was characterized by absence of MLH1, MSH6, MSH2 and/or PMS2 expression, evaluated by tissue microarrays. Overall survival (OS) and disease-free survival (DFS) were assessed using survival analysis., Results: Overall, 242 patients were included (males 57.4%, age 69.3 ± 12.9 years; median follow-up 49 months). RAS -mutated tumours were associated with reduced DFS ( p = 0.02) and OS ( p = 0.045) in stage I-III CRC. BRAF -mutated tumours were more predominant in females and in the right colon, similarly to dMMR tumours. BRAF status did not influence OS (4 years)/DFS (3.5 years) in stage I-III disease. However, after relapse, length of survival was 3.5 months in BRAF -mutated tumours in contrast to 18.6 months in BRAF wild-type tumours ( p = NS). No germline mutations in mismatch repair genes were so far identified in the patients with dMMR tumours. Molecular phenotype ( RAS, BRAF and MMR) did not influence OS in metastatic patients. Our small sample size may be a limitation of the study., Conclusion: In our cohort, RAS -mutated tumours were associated with worse DFS and OS in early-stage CRC, whereas the remaining molecular variables had no prognostic influence., Competing Interests: The authors declare that they have no competing interests., (Copyright © 2021 by S. Karger AG, Basel.)
- Published
- 2021
- Full Text
- View/download PDF
129. Loop ileostomy in rectal cancer surgery: factors predicting reversal and stoma related morbidity.
- Author
-
Ourô S, Ferreira MP, Albergaria D, and Maio R
- Subjects
- Anastomosis, Surgical, Humans, Morbidity, Postoperative Complications epidemiology, Postoperative Complications etiology, Retrospective Studies, Ileostomy adverse effects, Rectal Neoplasms surgery
- Abstract
Purpose: Loop ileostomy is performed in rectal cancer surgery to decrease the impact of anastomotic leak but it is associated with a significant complication rate. This study aimed to analyze the morbidity related to diverting ileostomy and to identify factors predictive of complications related to stoma management and reversal, as well as conversion into a permanent ileostomy., Methods: A retrospective study was conducted on 112 patients submitted to oncological rectal resection and defunctioning ileostomy in a Portuguese colorectal unit between March 2012 and March 2019., Results: Loop ileostomy was responsible for 13% of index surgery morbidity and 15% of patients' readmissions due to high output, stoma stenosis and parastomal hernia. Ileostomy was reversed in 89% cases with 7% Clavien-Dindo ≥ IIIb complications. An association was established between diabetes and higher stoma management morbidity (OR: 3.28 [95% CI: 1.039-10.426]. p = 0.041). Likewise, diabetes (OR: 0.17 [95% CI: 0.038; 6.90], p=0.015), oncological disease stage ≥ III (OR: 0.10 [95% CI: 0.005; 0.656], p=0.047) and index rectal surgery morbidity (OR: 0.23 [95% CI: 0.052; 0.955], p=0.041) were associated with less ileostomy closure. Complications of the index surgery also related to higher stoma reversal morbidity (OR: 5.11 [95% CI: 1.665; 16.346], p=0.005)., Conclusions: Diabetes and complications of index rectal surgery were identified as predictive of ileostomy morbidity, closure rate and associated complications. It is essential to adjust treatment decisions to patient's morbidity risk and adopt a more selective approach concerning the use of an ileostomy.
- Published
- 2021
- Full Text
- View/download PDF
130. Body Composition Influences Post-Operative Complications and 90-Day and Overall Survival in Pancreatic Surgery Patients.
- Author
-
Velho S, Costa Santos MP, Cunha C, Agostinho L, Cruz R, Costa F, Garcia M, Oliveira P, Maio R, Baracos VE, and Cravo M
- Abstract
Introduction: Pancreatic surgery still carries a high morbidity and mortality even in specialized centers. The aim of this study was to evaluate the influence of patients' body composition on postoperative complications and survival after pancreatic surgery., Methods: This was a retrospective study on patients undergoing pancreatic surgery between March 2012 and December 2017. Demographics, clinical data, and postoperative complications classified according to Clavien-Dindo were recorded. Body composition was assessed using routine diagnostic or staging computed tomography (CT). Multiple Cox proportional hazards models were adjusted., Results: Ninety patients were included, 55% were male, and the mean age was 68 ± 10.9 years. Of these 90, 92% had a total pancreatectomy or pancreaticoduodenectomy, 7% a distal pancreatectomy, and 1% a pancreaticoduodenectomy with multi-visceral resection; 84% had malignant disease. The incidence of major complications was 27.8% and the 90-day mortality was 8.8%. The ratio of visceral fat area/skeletal muscle area (VFA:SMA) was associated with an increased risk of complications (OR 2.24, 95% CI 1.14-4.87, p = 0.03) and 90-day survival (HR 2.13, 95% CI 1.13-4.01, p = 0.019). On simple analysis, shorter overall survival (OS) was observed in patients aged ≥70 years ( p = 0.0009), with postoperative complications ≥IIIb ( p = 0.01), an increased VFA:SMA ( p = 0.007), and decreased muscle radiation attenuation ( p = 1.6 × 10
-5 ). In an OS model adjusted for age, disease malignancy, postoperative complications, and body composition parameters, muscle radiation attenuation remained significantly associated with survival (HR 0.94, 95% CI 0.90-0.98, p = 0.0016). A model which included only body composition variables had a discrimination ability ( C -statistic 0.76) superior to a model which comprised conventional clinical variables ( C -statistic 0.68)., Conclusion: Body composition is a major determinant of postoperative complications and survival in pancreatic surgery patients., Competing Interests: There were no conflicts of interest., (Copyright © 2020 by Sociedade Portuguesa de Gastrenterologia. Published by S. Karger AG, Basel.)- Published
- 2020
- Full Text
- View/download PDF
131. Morestin Syndrome Beyond Thoracic Trauma.
- Author
-
Soares AW, Oliveira PV, Lopes B, Albergaria D, Ourô S, and Maio R
- Subjects
- Hemorrhage, Humans, Rupture, Syndrome, Fractures, Bone, Thoracic Injuries surgery
- Abstract
Morestin syndrome (MS) is a rare clinical manifestation consequent to an acute compression trauma to the thorax. In such an event, the sudden elevated pressure that happens to the airway and the rapid and retrograde blood flow results in capillary rupture in the head and neck vessel territory. This case reports a car accident victim that was dragged by a truck down a road with closed thoracic trauma resulting in MS. The patient presented with ecchymotic mask, neck and facial cyanosis and petechiae, ocular hemorrhage, otorrhagia, left clavicle fracture and spleen laceration that resolved with conservative measures. In this article, the authors present a specific acute syndrome due to trauma, with potential severe complications that should be recognized early and subject to a multidisciplinary and systemic approach in the emergency setting.
- Published
- 2020
132. [Giant Peritoneal Loose Body: Case Report and Review of Literature].
- Author
-
Oom R, Cunha C, Guedes VM, Féria LP, and Maio R
- Subjects
- Humans, Incidental Findings, Male, Middle Aged, Peritoneal Diseases surgery, Peritoneal Cavity pathology, Peritoneal Diseases pathology
- Abstract
Peritoneal loose bodies are usually diagnosed incidentally. Only a few cases are documented in the literature. The pathophysiology of this condition is not fully known and its origin may possibly be related to the twisting and separation of epiploic appendages. The authors describe the case of a patient with a spherical solid lesion 6 cm in diameter, identified incidentally in the pelvic cavity of a 64 year old man. The patient underwent laparotomy and a free ovoid shaped white body was identified. Histological examination described a calcified and encapsulated mass with a steato-necrosis core. A review of all cases of giant peritoneal loose bodies described in the literature is included. Surgical excision is recommended when the giant peritoneal loose body diagnosis is uncertain or when they are symptomatic. Doctors should be aware of its existence in order to establish a proper diagnosis and treatment plan.
- Published
- 2018
- Full Text
- View/download PDF
133. Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What's new?
- Author
-
Ferreira R, Loureiro R, Nunes N, Santos AA, Maio R, Cravo M, and Duarte MA
- Abstract
Benign biliary strictures comprise a heterogeneous group of diseases. The most common strictures amenable to endoscopic treatment are post-cholecystectomy, post-liver transplantation, related to primary sclerosing cholangitis and to chronic pancreatitis. Endoscopic treatment of benign biliary strictures is widely used as first line therapy, since it is effective, safe, noninvasive and repeatable. Endoscopic techniques currently used are dilation, multiple plastic stents insertion and fully covered self-expandable metal stents. The main indication for dilation alone is primary sclerosing cholangitis related strictures. In the vast majority of the remaining cases, temporary placement of multiple plastic stents with/without dilation is considered the treatment of choice. Although this approach is effective, it requires multiple endoscopic sessions due to the short duration of stent patency. Fully covered self-expandable metal stents appear as a good alternative to plastic stents, since they have an increased radial diameter, longer stent patency, easier insertion technique and similar efficacy. Recent advances in endoscopic technique and various devices have allowed successful treatment in most cases. The development of novel endoscopic techniques and devices is still ongoing.
- Published
- 2016
- Full Text
- View/download PDF
134. Towards curative therapy in gastric cancer: Faraway, so close!
- Author
-
Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, and Maio R
- Subjects
- Animals, Chemotherapy, Adjuvant, Disease-Free Survival, Humans, Neoplasm Micrometastasis, Neoplasm Recurrence, Local, Neoplasm, Residual, Precision Medicine, Risk Factors, Stomach Neoplasms genetics, Stomach Neoplasms mortality, Stomach Neoplasms pathology, Treatment Outcome, Chemoradiotherapy, Adjuvant adverse effects, Chemoradiotherapy, Adjuvant mortality, Gastrectomy adverse effects, Gastrectomy mortality, Neoadjuvant Therapy adverse effects, Neoadjuvant Therapy mortality, Stomach Neoplasms therapy
- Abstract
Although recent diagnostic and therapeutic advances have substantially improved the survival of patients with gastric cancer (GC), the overall prognosis is still poor. Surgery is the only curative treatment and should be performed in experienced centers. Due to high relapse following surgery, complementary and systemic treatment aimed at eradicating micrometastasis should be performed in most cases. Cytotoxic treatments are effective in downstaging locally advanced cancer, but different sensitivities and toxicities probably exist in different GC subtypes. Current treatment protocols are based primarily on clinical data and histological features, but molecular biomarkers that would allow for the prediction of treatment responses are urgently needed. Understanding how host factors are responsible for inter-individual variability of drug response or toxicity will also contribute to the development of more effective and less toxic treatments.
- Published
- 2015
- Full Text
- View/download PDF
135. Laparoscopic placement of Tenckhoff catheters for peritoneal dialysis: a safe, effective, and reproducible procedure.
- Author
-
Maio R, Figueiredo N, and Costa P
- Subjects
- Adult, Aged, Aged, 80 and over, Catheterization adverse effects, Female, Humans, Male, Middle Aged, Catheterization methods, Catheters, Indwelling adverse effects, Laparoscopy, Peritoneal Dialysis
- Abstract
Background/aims: Currently there are several techniques for laparoscopic placement of peritoneal dialysis catheters. The aim of this paper is to describe our technique and outcomes., Patients and Methods: Laparoscopic implantation of peritoneal catheters was performed in 100 consecutive patients. The technique employed laparoscopically guided musculofascial tunneling to maintain catheter orientation toward the deep pelvis, and adhesiolysis to eliminate compartmentalization that could affect completeness of dialysate drainage. Mean duration of surgery, hospital stay, morbidity, mortality, and catheter survival were assessed. Analysis of catheter survival was performed using the Kaplan-Meier method, with censoring of catheter loss due to death or successful transplantation., Results: Mean operative time was 20 +/- 7 minutes and average duration of hospital stay was 3 +/- 1 days. There were no conversions from laparoscopy to conventional catheter insertion methods. No exit-site or tunnel infections, hemorrhagic complications, abdominal wall hernias, or catheter cuff extrusions were detected. No mortality occurred in this series of patients. Catheter survival was 97%, 95%, and 91% at 1, 2, and 3 years, respectively., Conclusions: The laparoscopic method described in this report is compliant with consensus guidelines for best-demonstrated practices in peritoneal access placement. Laparoscopy permits direct visualization of all procedure steps in a safe efficient reproducible manner. The laparoscopic approach afforded patients the advantage of short procedure times, a minimally invasive approach, and excellent outcomes. The results reported in this paper support our opinion that laparoscopic Tenckhoff catheter implantation should become the standard of care for clinical practice.
- Published
- 2008
136. [Evaluation of different preservation solutions utilized in the machine perfusion of kidneys retrieved under cardiac arrest. An experimental study].
- Author
-
Maio R, Costa P, Figueiredo N, and Santos I
- Subjects
- Animals, Swine, Tissue and Organ Harvesting, Heart Arrest, Kidney, Organ Preservation methods, Organ Preservation Solutions
- Abstract
Considering the special demands of organs retrieved after cardiac death, the solution that should optimize and preserve the best early graft function and long-term graft survival remains to be determined. Recently, polyethylene glycol (PEG), high-molecular weight colloid, due to its protective effect against ischemia and reperfusion injury, has been proposed to be added to different preservation solutions for cold storage. Celsior formulation was targeted to fulfil the principles of organ preservation. The aim of our study was to evaluate Celsior plus PEG as a machine perfusion solution for kidneys retrieved after cardiac death. Landrace pigs were killed by lethal injection. Kidneys were submitted to warm and cold ischemic injuries mimicking the injury suffered by donation after cardiac death and were machine perfused with Celsior, Celsior plus 30 mg/l of PEG 20,000 Da and Belzer MPS. We demonstrate that when kidneys, submitted to warm and cold ischemia injury, were machine perfused with Celsior plus PEG the IRR were lower and the renal flow rates were higher in comparison with Celsior alone or Belzer MPS in the same conditions. This study provides the first evidence that Celsior plus PEG is an effective solution for machine perfusion of kidneys retrieved after cardiac death.
- Published
- 2007
137. [Mycotic rupture of the reno-external iliac artery anastomosi following kidney transplantation].
- Author
-
Maio R, do Carmo G, do Vale JM, and da Gama AD
- Subjects
- Adult, Anastomosis, Surgical adverse effects, Candidiasis etiology, Humans, Male, Rupture, Spontaneous, Vascular Diseases etiology, Candidiasis complications, Iliac Artery surgery, Kidney Transplantation adverse effects, Renal Artery surgery, Vascular Diseases complications, Vascular Diseases microbiology
- Abstract
Two clinical cases of an unusual complication of the renal transplantation are reported, consisting in the infection of the arterial wall by fungi of the species Candida Albicans and Aspergillus, which caused acute ruptures of the external iliac artery and hypovolemic shock. The main features of the pathogenesis of the infection, its diagnosis, management and prevention are subjected to analysis and discussion.
- Published
- 2004
138. ["Ex-vivo" renal artery revascularization].
- Author
-
Carmo Gd Gd, Maio R, Romero M, Rosa A, and Da Gama AD
- Subjects
- Humans, Hypertension, Renovascular, Kidney Transplantation, Renal Artery Obstruction, Kidney, Renal Artery
- Abstract
Three patients with renovascular hypertension due to complex and branch lesions of the renal artery are reported, successfully managed by a technique consisting in the "ex-vivo" repair of the lesions followed by kidney autotransplantation. The indications and technical details of the procedure are subjected to a description and discussion.
- Published
- 2003
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.